Health Minister Mark Butler has challenged states and territories that have banned puberty blockers for children to comply with new national guidelines, which recommended gender-diverse teens get access to the treatment.
The federal government announced a landmark review into the medical treatment of transgender children and adolescents in January 2025, after Queensland and the Northern Territory paused the prescription of gender transition drugs, including puberty blockers, for young people.
The review was ordered after the United Kingdom banned puberty blockers in 2024 after a health service commission found there was little scientific evidence to support the treatment. The UK is now running a clinical trial to assess the risks and benefits of puberty-blocking medication.
“I’m very confident that those state governments running these services will consider this advice very closely and make sure that their services are aligning with it,” Butler told reporters in Canberra.
“I know traditionally, state governments of both political persuasions have always paid high regard to the advice of the National Health and Medical Research Council.”
Under the NHMRC’s proposed national guidelines a child must have begun to show physical signs of puberty, have an inconsistency between their gender and sex recorded at birth, and be assessed as suitable by appropriate clinicians and in consultation with parents.
“I have the utmost respect for the National Health and Medical Research Council, and I think the role that it has long played in this country at arm’s length from the government of the day and the political process to provide the highest quality clinical advice to health practitioners and the community generally should always be respected,” Butler said.
“That’s why I asked them to try and review the evidence, and issue some preeminent guidelines to guide this contested, evolving area that’s the subject of so much public commentary and involves some of our most vulnerable members of the community.”
The debate around the use of puberty blockers was not always constructive and could be damaging to the mental health of young people and their families, Butler said.
The NHMRC advice on puberty blockers is an interim guideline ahead of its broader recommendations on gender-affirming care such as the prescription of hormones, expected in 2028.
Cut through the noise of federal politics with news, views and expert analysis. Subscribers can sign up to our weekly Inside Politics newsletter.
From our partners
Disclaimer : This story is auto aggregated by a computer programme and has not been created or edited by DOWNTHENEWS. Publisher: www.smh.com.au







